ANDA 88642, held by Teva. Diethylpropion Hydrochloride.
As of Nov 16, 2026, ANDA 88642 (Diethylpropion Hydrochloride), held by Teva, was first approved by FDA on Sep 20, 1984, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 20, 1984 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Diethylpropion Hydrochloride25MG ยท tablet;oral | Diethylpropion Hydrochloride | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters